| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | Aug 12, 2025 | Protalix BioTherapeutics, Inc. | Director | Buy | 95.0 | +129,000 | 74.14% | ✗ | $205.9K |
| Jan 3, 2023 | Jan 5, 2023 | Protalix BioTherapeutics, Inc. | Director | Buy | 95.0 | +110,000 | 171.88% | ✗ | $155.8K |
| Apr 7, 2020 | Apr 13, 2020 | Protalix BioTherapeutics, Inc. | Director | Buy | 95.0 | +64,000 | 100.00% | ✗ | $155.3K |